The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease

Author(s): D. N. Streblow, S. L. Orloff, J. A. Nelson

Journal Name: Current Drug Targets - Infectious Disorders
Continued as Infectious Disorders - Drug Targets

Volume 1 , Issue 2 , 2001


The human cytomegalovirus (HCMV) has been implicated in the acceleration of vascular disease for some time. The development of vascular disease involves a chronic inflammatory process with many contributing factors, and of these, chemokines and their receptors have recently been identified as key mediators. Interestingly, HCMV encodes four potential chemokine receptors (US27, US28, UL33 and UL78). Of these virally-encoded chemokine receptors, US28 has been the most widely characterized. US28 binds many of the CC-chemokines, and this class of chemokines contributes to the development of vascular disease. Importantly, HCMV infection mediates in vitro SMC migration, which is dependent upon expression of US28 and CC-chemokine binding. US28 and the US28 functional homologues that are capable of inducing the migration of SMC represent potential targets in the treatment of CMV-accelerated vascular disease such as atherosclerosis, restenosis, and transplant vascular sclerosis

Keywords: HCMV Chemokine Receptor, atherosclerosis, restenosis, transplant vascular sclerosis, HERPESVIRUS, CHEMOKINE RECEPTORS

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Published on: 01 March, 2012
Page: [151 - 158]
Pages: 8
DOI: 10.2174/1568005014606080
Price: $65

Article Metrics

PDF: 4